Paper Details

  1. Home
  2. Paper Details

Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients.

Author: ConnellB J, HoepelmanA I M, NijhuisM, SymonsJ, WensingA M J, van HamP, van LelyveldS F L

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This cohort study analyzed the clinical outcomes of HIV-1-infected patients treated with maraviroc (MVC). Treatment with MVC was well tolerated and resulted in good immunological and virological responses. The predictive values of different tropism assays were comparably high.
Paper Details　
Original Abstract of the Article :
Available data on the use of maraviroc (MVC) in clinical settings are limited. In this cohort study, the clinical outcomes of HIV-1-infected patients treated with MVC were analysed and the predictive values of different tropism assays were compared. Baseline viral tropism was assessed and compared b...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ijantimicag.2015.09.013

データ提供：米国国立医学図書館（NLM）

Maraviroc in the Treatment of HIV: A New Weapon in the Desert of AIDS

The fight against HIV has been a long and arduous journey through a vast and unforgiving desert. This study investigates the effectiveness of maraviroc (MVC), a medication used to treat HIV-1 infection, in patients who have received extensive prior treatment. Researchers conducted a cohort study to assess the clinical outcomes of MVC treatment in patients with HIV-1. Their findings suggest that MVC is well-tolerated and can effectively control viral load, leading to significant improvements in immune function. This is a beacon of hope in the desert of HIV-1 treatment, offering a potential lifeline for individuals who have exhausted other treatment options.

A Beacon of Hope in the Desert: MVC's Effectiveness

The results of this study indicate that MVC is a valuable tool in the desert of HIV-1 treatment. It has been shown to be effective in controlling viral load and improving immune function, potentially offering a new hope for individuals with HIV-1.

Navigating the Desert: Living with HIV

This research emphasizes the importance of personalized treatment approaches for HIV-1 infection. It's like navigating a desert with a compass and map, where each individual's journey is unique. Consulting with a healthcare provider is crucial to determine the best course of treatment.

Dr.Camel's Conclusion

This study shows the potential of MVC to be a valuable weapon in the desert of AIDS treatment. Its effectiveness in controlling HIV-1 viral load and improving immune function is encouraging. However, we must continue to strive for new and innovative treatment options to fully conquer this desert.

Date :
  1. Date Completed 2016-10-17
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26585497

DOI: Digital Object Identifier

10.1016/j.ijantimicag.2015.09.013

Related Literature

Article Analysis
・Side Effects of maraviroc
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.